Our Recommendations
New Publications
- Introdução breve: Formação da Vacina contra a Malária (2025)
- Trousses de formation essentiel pour l’introduction du vaccin contre le paludisme (2025)
- Essential Training Packages for Malaria Vaccine Introduction (2025)
- Malaria vaccines. Summary of the WHO position paper (2024)
- RTS,S/AS01 malaria vaccine current evidence, including efficacy, safety, feasibility and impact and update on R21/Matrix-M malaria vaccine (2023)
Filter
21
Featured
Recommendations
3
Language
Document type
Studies & Reports
9
Training Material
6
Manuals
3
Fact sheets
2
Resource Platforms
1
Authors & Publishers
Publication Years
Category
Front. Malar. 3:1336324. doi: 10.3389/fmala.2025.1336324
A VaccinesWork guide: news, science explainers and reported dispatches giving you everything you need to know about the world’s first malaria vaccine and its historic roll-out.
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
Questions and answers
Brief Introduction Malaria Vaccine Training. For countries planning malaria vaccine introduction, WHO has developed training packages of slide sets on key topics for health workers in English and French that can be downloaded and customized to meet specific country needs:
Brève introduction: Formation au vaccin contre le paludisme. Pour les pays planifiant l’introduction du vaccin contre le paludisme, l’OMS a développé des trousses de formation comprenant des séries de diapositives en anglais et en français sur des sujets clés destinés aux agents de santé...
Programa de Implementação da Vacina contra a Malária: 2019 – 2023.
This position paper supersedes the 2022 WHO position paper on malaria vaccines. It includes the updated WHO recommendations on the use of the RTS,S/AS01 and R21/Matrix-M vaccines for the reduction of malaria morbidity and mortality in children living in endemic areas, prioritizing areas of moderate ...
The following appendices of the Guide for introducing a malaria vaccine containing key messages are available for country adaptation
Guide pour l’introduction du vaccin contre le paludisme dans les programmes nationaux de vaccination
Messages clés sur la vaccination antipaludique à adapter par les pays
Annexe 1. Informations sur le vaccin contre le paludisme destinées aux agents de santé (pour l’introduction du vacci...
Two malaria vaccines are currently WHO prequalified and recommended1 for use to prevent
P. falciparum malaria in young children, the RTS,S/AS01 vaccine, currently manufactured by
GlaxoSmithKline (GSK), and the R21/Matrix-M vaccine, manufactured by Serum Institute of India
Pvt (SII)
Deux vaccins antipaludiques sont actuellement préqualifiés et recommandés par l'OMS1 pour prévenir
le paludisme à P. falciparum chez les jeunes enfants : le vaccin RTS,S/AS01, actuellement fabriqué par
GlaxoSmithKline (GSK), et le vaccin R21/Matrix-M, fabriqué par Serum Institute of India
...
Lancet Microbe 2024; 5: e519
Lancet 2024; 403: 533–44
R21/Matrix-M was well tolerated and offered high efficacy against clinical malaria in African children. This
low-cost, high-efficacy vaccine is already licensed by several African countries, and recently received a WHO policy
recommendation and prequalification, offerin...
WHO position paper on malaria vaccines, Weekly Epidemiological Record 10 May 2024
This practical document is available to support programmes and partners to design and implement risk communication strategies to achieve high uptake of malaria vaccination.
This practical document is available to support programmes and partners to design and implement risk communication strategies to achieve high uptake of malaria vaccination.
Malaria vaccines: the 60‑year journey of hope and final success—lessons learned and future prospects
Tropical Medicine and Health (2023) 51:29
Presentation OPT-SMC malaria vaccine workshop - Jan 2023
